Literature DB >> 21910984

Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.

Min Lin1, Oluyemi Aladejebi, Gregory H Hockerman.   

Abstract

The binding site within the L-type Ca(2+) channel Ca(v)1.2 for neutral dihydropyridines is well characterized. However, the contributions of the alkylamino side chains of charged dihydropyridines such as amlodipine and nicardipine to channel block are not clear. We tested the hypothesis that the distinct locations of the charged side chains on amlodipine and nicardipine would confer distinct properties of channel block by these two drugs. Using whole-cell voltage clamp, we investigated block of wild type Ca(v) 2.1, wild type Ca(v)1.2, and Ca(v)1.2/Dihydropyridine insensitive, a mutant channel insensitive to neutral DHPs, by amlodipine and nicardipine. The potency of nicardipine and amlodipine for block of closed (stimulation frequency of 0.05 Hz) Ca(v)1.2 channels was not different (IC(50) values of 60 nM and 57 nM, respectively), but only nicardipine block was enhanced by increasing the stimulation frequency to 1 Hz. The frequency-dependent block of Ca(v)1.2 by nicardipine is the result of a strong interaction of nicardipine with the inactivated state of Ca(v)1.2. However, nicardipine block of Ca(v)1.2/Dihydropyridine insensitive was much more potent than block by amlodipine (IC(50) values of 2.0 μM and 26 μM, respectively). A mutant Ca(v)2.1 channel containing the neutral DHP binding site (Ca(v)2.1/Dihydropyridine sensitive) was more potently blocked by amlodipine (IC(50)=41 nM) and nicardipine (IC(50)=175 nM) than the parent Ca(v)2.1 channel. These data suggest that the alkylamino group of nicardipine and amlodipine project into distinct regions of Ca(v)1.2 such that the side chain of nicardipine, but not amlodipine, contributes to the potency of closed-channel block, and confers frequency-dependent block.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910984      PMCID: PMC3193569          DOI: 10.1016/j.ejphar.2011.08.005

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  35 in total

1.  Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels.

Authors:  G H Hockerman; N Dilmac; T Scheuer; W A Catterall
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

2.  Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel.

Authors:  S B Ellis; M E Williams; N R Ways; R Brenner; A H Sharp; A T Leung; K P Campbell; E McKenna; W J Koch; A Hui; A Schwartz; M M Harpold
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

3.  Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents.

Authors:  J E Arrowsmith; S F Campbell; P E Cross; J K Stubbs; R A Burges; D G Gardiner; K J Blackburn
Journal:  J Med Chem       Date:  1986-09       Impact factor: 7.446

4.  Synthesis of new water-soluble dihydropyridine vasodilators.

Authors:  M Iwanami; T Shibanuma; M Fujimoto; R Kawai; K Tamazawa; T Takenaka; K Takahashi; M Murakami
Journal:  Chem Pharm Bull (Tokyo)       Date:  1979-06       Impact factor: 1.645

5.  Molecular determinants of Ca2+ potentiation of diltiazem block and Ca2+-dependent inactivation in the pore region of cav1.2.

Authors:  Nejmi Dilmac; Nathan Hilliard; Gregory H Hockerman
Journal:  Mol Pharmacol       Date:  2003-08       Impact factor: 4.436

6.  Secretory and vascular effects of the optical isomers of nicardipine.

Authors:  K Iwatsuki; F Iijima; S Chiba
Journal:  Clin Exp Pharmacol Physiol       Date:  1984 Jan-Feb       Impact factor: 2.557

7.  A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine.

Authors:  Yoriko Miyashita; Taiji Furukawa; Etsuko Kamegaya; Mitsunobu Yoshii; Toshihide Nukada
Journal:  Eur J Pharmacol       Date:  2010-01-22       Impact factor: 4.432

8.  Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells.

Authors:  K S Lee; R W Tsien
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

9.  Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors.

Authors:  R A Burges; D G Gardiner; M Gwilt; A J Higgins; K J Blackburn; S F Campbell; P E Cross; J K Stubbs
Journal:  J Cardiovasc Pharmacol       Date:  1987-01       Impact factor: 3.105

10.  Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor.

Authors:  R S Kass; J P Arena
Journal:  J Gen Physiol       Date:  1989-06       Impact factor: 4.086

View more
  6 in total

Review 1.  Beta-Cell Ion Channels and Their Role in Regulating Insulin Secretion.

Authors:  Benjamin Thompson; Leslie S Satin
Journal:  Compr Physiol       Date:  2021-10-12       Impact factor: 9.090

Review 2.  Ca²⁺ channels and praziquantel: a view from the free world.

Authors:  John D Chan; Magdalena Zarowiecki; Jonathan S Marchant
Journal:  Parasitol Int       Date:  2012-12-16       Impact factor: 2.230

3.  Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influx.

Authors:  Rachel E Jarrard; Yuchen Wang; Amy E Salyer; Evan P S Pratt; Ian M Soderling; Marcy L Guerra; Allison M Lange; Hilary J Broderick; Gregory H Hockerman
Journal:  Mol Pharmacol       Date:  2012-10-15       Impact factor: 4.436

4.  PKC independent inhibition of voltage gated calcium channels by volatile anesthetics in freshly isolated vascular myocytes from the aorta.

Authors:  Mohammed Fanchaouy; Luis Cubano; Hector Maldonado; Rostislav Bychkov
Journal:  Cell Calcium       Date:  2013-08-13       Impact factor: 6.817

5.  Encapsulation of Nicardipine Hydrochloride and Release from Biodegradable Poly(D,L-lactic-co-glycolic acid) Microparticles by Double Emulsion Process: Effect of Emulsion Stability and Different Parameters on Drug Entrapment.

Authors:  Nopparuj Soomherun; Narumol Kreua-Ongarjnukool; Sorayouth Chumnanvej; Saowapa Thumsing
Journal:  Int J Biomater       Date:  2017-11-08

6.  The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study.

Authors:  Lauren Z Atkinson; Lucy Colbourne; Alexander Smith; Catherine H Harmer; Anna C Nobre; Jennifer Rendell; Helen Jones; Christopher Hinds; Arne Mould; Elizabeth M Tunbridge; Andrea Cipriani; John R Geddes; Kate E A Saunders; Paul J Harrison
Journal:  Trials       Date:  2019-02-12       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.